Related Experiment Video
Updated: Apr 27, 2026

Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis
Published on: March 20, 2021
Generic change indicators in therapeutic processes with different outcomes.
Mariane Krause1, Carolina Altimir, Janet Carola Pérez
1a Department of Psychology , Pontificia Universidad Católica de Chile , Santiago , Chile.
Therapies with good outcomes showed more advanced change indicators (Stage III GCIs) and linked early progress to later stages. Poor outcome therapies had more early-stage indicators without connection to later progress.
Area of Science:
- Psychology
- Psychotherapy Research
Background:
- Understanding the link between the therapeutic process and its outcome is crucial for effective interventions.
- Naturalistic settings offer valuable insights into real-world therapy dynamics.
Purpose of the Study:
- To analyze the relationship between ongoing change indicators and final therapeutic outcomes in naturalistic settings.
- To explore how different stages of change (GCIs) relate to therapy success.
Main Methods:
- Assessed ongoing change using generic change indicators (GCIs) across 19 complexity levels, grouped into three stages.
- Measured therapy outcome using Lambert's Outcome Questionnaire (OQ 45.2).
- Calculated productivity indicators for GCIs, adjusted for therapy length and individual production.
Main Results:
- Good outcome therapies exhibited a higher frequency of Stage III GCIs.
- A significant association was found between Stage I GCI productivity and later stages (II and III) in good outcome cases.
- Poor outcome therapies showed increased early-stage GCI productivity without correlation to advanced stages.
Conclusions:
- Ongoing change, particularly advanced stages, is related to positive therapeutic outcomes.
- Generic change indicators (GCIs) show potential for monitoring therapy progress in clinical practice.
Related Concept Videos
Therapeutic Drug Monitoring: Drug Analysis Methods
Therapeutic Drug Monitoring: Affecting Factors
Therapeutic Drug Monitoring: Overview and Classification
Measurement of Bioavailability: Pharmacodynamic Methods
Guidelines For Measuring Vital Signs
Before taking a patient's vital signs, a nurse would consider and assess the patient's comfort level and ensure appropriate equipment is available.
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

